The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Approval was based on data from two phase 3 clinical ...
Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include novel drugs that offer new treatment options, as well as first generics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback